Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
deregulations involved in the development and progression of human lymphomas. The successful candidate will contribute to a research program aimed at generating, interpreting, and developing in vivo CRISPR Cas9
-
innovative therapies. The Functional Genomics Expertise Center provides advanced genome editing, CRISPR screening, and functional genomics support to research groups across CCB. We are seeking a molecular
-
innovative therapies. The Functional Genomics Expertise Center provides advanced genome editing, CRISPR screening, and functional genomics support to research groups across CCB. We are seeking a molecular
-
peuplier, une espèce modèle à croissance rapide et d'une grande importance économique. La thèse utilisera la technologie CRISPR-Cas pour éditer le génome des peupliers et combiner rapidement des allèles
-
disease, particularly in the context of therapy resistance in colorectal cancer. We are looking for an ambitious cancer biologist to work in Dr Li laboratory who can integrate functional CRISPR screens with
-
HBIGS Heidelberg Biosciences International Graduate School | Heidelberg, Baden W rttemberg | Germany | 8 days ago
, stem cell homeostasis, proliferation and differentiation and is frequently dysregulated in human cancer. In this project you will develop and apply advanced CRISPR genome engineering methods
-
of São Paulo (UNIFESP), in Brazil, aims to investigate how CRISPR-Cas9-mediated genetic modification of Invariant Natural Killer T (iNKT) cells can modulate their antitumor activity and therapeutic
-
-targeting CRISPR systems (Zolboot et al. in preparation), and single-cell, isoform-sensitive measurements of translation in vivo (Ribo-STAMP; Sison et al. Nature 2026). Using these tools, we have identified
-
the manufacturing challenges associated with producing rAAV and brings together experts from two leading Irish institutions, NIBRT and UCD, and APC-VLE Ltd. (https://approcess.com/services/cell-and-gene-therapies
-
our publications here . Our team is at the forefront of bringing autologous cell replacement therapies with CRISPR-edited muscle stem cells towards the clinic (https://www.mdc-berlin.de/news/news/deep